Analysts expect Coherus Oncology, Inc. to report revenue of 16.25 M for Q3 26, against a range of 15.03 M to 17.48 M. The most recent reported quarter, Q2 26, came in at 14.31 M, a 4.6% miss against the 15.00 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 70.77 M | 54.14 M | 7.60 M | 10.25 M | 11.57 M | 12.75 M | 12.31 M | 14.31 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 68.04 M | 44.97 M | 59.06 M | 10.54 M | 15.06 M | 15.59 M | 16.19 M | 15.85 M | 17.48 M | 18.63 M | 20.90 M | 26.10 M | 25.78 M | 25.01 M | 38.28 M | 47.10 M | ||||||||||
| Low Estimate | 55.70 M | 40.52 M | 55.03 M | 9.44 M | 13.08 M | 13.52 M | 14.00 M | 14.14 M | 15.03 M | 15.59 M | 18.03 M | 23.30 M | 23.37 M | 21.18 M | 31.76 M | 38.80 M | ||||||||||
| Consensus Estimate | 61.87 M | 42.75 M | 57.04 M | 9.99 M | 14.07 M | 14.56 M | 15.10 M | 15.00 M | 16.25 M | 17.11 M | 19.46 M | 24.70 M | 24.57 M | 23.10 M | 35.02 M | 42.95 M |
Analysts expect Coherus Oncology, Inc. to report earnings per share of -0.22 for Q3 26, against a range of -0.24 to -0.20. The most recent reported quarter, Q2 26, came in at -0.22, a 8.3% beat against the -0.24 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.09 | -0.44 | -0.41 | -0.39 | -0.31 | -0.39 | -0.27 | -0.22 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.15 | -0.30 | -0.28 | -0.20 | -0.31 | -0.34 | -0.20 | -0.22 | -0.20 | -0.19 | -0.20 | -0.19 | -0.21 | -0.21 | -0.11 | -0.08 | ||||||||||
| Low Estimate | -0.17 | -0.34 | -0.34 | -0.22 | -0.35 | -0.40 | -0.22 | -0.26 | -0.24 | -0.23 | -0.24 | -0.23 | -0.23 | -0.25 | -0.13 | -0.10 | ||||||||||
| Consensus Estimate | -0.16 | -0.32 | -0.31 | -0.21 | -0.33 | -0.37 | -0.21 | -0.24 | -0.22 | -0.21 | -0.22 | -0.21 | -0.22 | -0.23 | -0.12 | -0.09 |
Pull Wall Street consensus for Coherus Oncology, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CHRS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CHRS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CHRS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();